- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
News 260 results
Recognition
November 6, 2025
Best Lawyers Names King & Spalding Law Firm of the Year for FDA Law and Recognizes 41 Practices in its 2026 “Best Law Firms” Guide
Recognition
November 5, 2025
Securities Docket Names Six King & Spalding Partners to its “Enforcement Elite” List
Cases & Deals
October 29, 2025
King & Spalding Advises Sullivan Brothers Family of Companies on the Acquisition of Texas-based Cotton Holdings, Inc.
Recognition
October 28, 2025
Benchmark Litigation Recognizes King & Spalding as a Leading Litigation Firm
Cases & Deals
Cases & Deals
September 30, 2025
U.S. Based Global Commercial and Financial Bank and European-Headquartered Global Investment Bank Complete the Sale and Purchase of Secured Media Asset-Backed Notes
Recognition
September 12, 2025
King & Spalding Named Finalists for Three Honors at 2025 National Law Journal Awards
Cases & Deals
September 10, 2025
European-Headquartered Global Investment Bank Completes Issuance of Secured Fiber Variable Funding Notes
In the News · Source: Law360 Pulse, Daily Report, The National Law Journal, Bloomberg Law, The Daily Docket, Thomson Reuters Westlaw Today and Global Legal Chronicle
Press Release
August 26, 2025
David Hoskins, Former Lead Litigation Counsel for the Centers for Medicare & Medicaid Services, Joins King & Spalding
Cases & Deals
August 25, 2025
King & Spalding Obtains Fourth Circuit Reversal of Class Certification for Progressive